» Articles » PMID: 23612789

Differential Targeting of the Dopamine Transporter to Recycling or Degradative Pathways During Amphetamine- or PKC-regulated Endocytosis in Dopamine Neurons

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2013 Apr 25
PMID 23612789
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine transporter (DAT) clears the extracellular dopamine released during neurotransmission and is a major target for both therapeutic and addictive psychostimulant amphetamines. Amphetamine exposure or activation of protein kinase C (PKC) by the phorbol ester PMA has been shown to down-regulate cell surface DAT. However, in dopamine neurons, the trafficking itinerary and fate of internalized DAT has not been elucidated. By monitoring surface-labeled DAT in transfected dopamine neurons from embryonic rat mesencephalic cultures, we find distinct sorting and fates of internalized DAT after amphetamine or PMA treatment. Although both drugs promote DAT internalization above constitutive endocytosis in dopamine neurons, PMA induces ubiquitination of DAT and leads to accumulation of DAT on LAMP1-positive endosomes. In contrast, after amphetamine exposure DAT is sorted to recycling endosomes positive for Rab11 and the transferrin receptor. Furthermore, quantitative assessment of DAT recycling using an antibody-feeding assay reveals that significantly less DAT returns to the surface of dopamine neurons after internalization by PMA, compared with vehicle or amphetamine treatment. These results demonstrate that, in neurons, the DAT is sorted differentially to recycling and degradative pathways after psychostimulant exposure or PKC activation, which may allow for either the transient or sustained inhibition of DAT during dopamine neurotransmission.

Citing Articles

Interactions of VMAT2 with CDCrel-1 and Parkin in Methamphetamine Neurotoxicity.

Chauhan H, Carruthers N, Stemmer P, Schneider B, Moszczynska A Int J Mol Sci. 2024; 25(23).

PMID: 39684782 PMC: 11642102. DOI: 10.3390/ijms252313070.


Dopamine transporter endocytic trafficking: Neuronal mechanisms and potential impact on DA-dependent behaviors.

Bolden N, Pavchinskiy R, Melikian H J Neurochem. 2024; 169(1):e16284.

PMID: 39655745 PMC: 11631176. DOI: 10.1111/jnc.16284.


Monoamine transporter ubiquitination and inward-open conformation synergistically maximize transporter endocytosis.

Sorkina T, Bagalkot T, Cheng M, Guthrie D, Newman A, Watkins S Sci Adv. 2024; 10(47):eadq9793.

PMID: 39576869 PMC: 11584022. DOI: 10.1126/sciadv.adq9793.


Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum.

Chauhan H, Carruthers N, Stemmer P, Schneider B, Moszczynska A bioRxiv. 2024; .

PMID: 39091864 PMC: 11291068. DOI: 10.1101/2024.07.21.604458.


Amphetamine Induces Sex-Dependent Loss of the Striatal Dopamine Transporter in Sensitized Mice.

Bagalkot T, Sorkin A eNeuro. 2024; 11(1).

PMID: 38164591 PMC: 10849026. DOI: 10.1523/ENEURO.0491-23.2023.


References
1.
Sulzer D . How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron. 2011; 69(4):628-49. PMC: 3065181. DOI: 10.1016/j.neuron.2011.02.010. View

2.
Mellman I, Plutner H, Ukkonen P . Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment. J Cell Biol. 1984; 98(4):1163-9. PMC: 2113231. DOI: 10.1083/jcb.98.4.1163. View

3.
Doolen S, Zahniser N . Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther. 2001; 296(3):931-8. View

4.
Eriksen J, Bjorn-Yoshimoto W, Jorgensen T, Newman A, Gether U . Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons. J Biol Chem. 2010; 285(35):27289-27301. PMC: 2930728. DOI: 10.1074/jbc.M110.131003. View

5.
Scott D, Michailidis I, Mu Y, Logothetis D, Ehlers M . Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J Neurosci. 2004; 24(32):7096-109. PMC: 6729175. DOI: 10.1523/JNEUROSCI.0780-04.2004. View